Acumen Pharmaceuticals Inc (ABOS) — Defensive Interval Ratio
Acumen Pharmaceuticals Inc (ABOS) has a Defensive Interval Ratio of 957 days as of March 2026. Defensive assets of $76.60 Million (cash $-, short-term investments $76.60 Million, receivables $-) cover 957 days of daily cash needs of $80.08K/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Acumen Pharmaceuticals Inc Defensive Interval Ratio (2019–2025)
This chart shows how Acumen Pharmaceuticals Inc's Defensive Interval Ratio has evolved across 7 annual periods from 2019 to 2025. As of March 2026, the ratio stands at 957 days, meaning defensive assets of $76.60 Million can fund 957 days of operations without new revenue. For the complete balance sheet picture, see ABOS current and non-current assets.
Annual Defensive Interval Ratio for Acumen Pharmaceuticals Inc (2019–2025)
The table below presents the year-by-year Defensive Interval Ratio for Acumen Pharmaceuticals Inc from 2019 to 2025, covering 7 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See working capital to net assets of Acumen Pharmaceuticals Inc to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 772 days | $63.50 Million | $82.21K/day | $- | $62.88 Million | ▼ -1030 days |
| 2024 | 1802 days | $136.33 Million | $75.64K/day | $- | $135.93 Million | ▼ -3174 days |
| 2023 | 4977 days | $176.86 Million | $35.54K/day | $- | $176.64 Million | ▲ +2757 days |
| 2022 | 2220 days | $47.50 Million | $21.40K/day | $- | $47.50 Million | ▼ -2892 days |
| 2021 | 5111 days | $72.07 Million | $14.10K/day | $- | $72.08 Million | ▲ +5105 days |
| 2020 | 6 days | $109.00K | $17.44K/day | $- | $0.00 | ▼ -2 days |
| 2019 | 8 days | $30.00K | $3.68K/day | $- | $- | — |